Literature DB >> 881879

Chondrosarcoma: a case report with left atrial involvement and systemic embolization.

T W Boland, E R Winga, B Kalfayan.   

Abstract

A 26-year-old white man underwent amputation of the right lower extremity for a chondrosarcoma of the distal femur. Eleven years later, after a long symptom-free interval, he was hospitalized for rapidly progressive dyspnea, pleuritic chest pain, and hemoptysis resulting from a large pulmonary metastasis that had extended directly to the left atrium via the pulmonary vein. Within 24 hours of hospitalization, obstruction of the left commom iliac artery by tumor embolus necessitated embolectomy. This represents the second report of a metastatic chondrosarcoma involving the left atrium. The case presented clinically as an atrial myxoma and disseminated via the systemic circulation with a rapidly downhill course therafter.

Entities:  

Mesh:

Year:  1977        PMID: 881879

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Left atrial metastasis presenting as recurrent embolic strokes.

Authors:  N Chalmers; I W Campbell
Journal:  Br Heart J       Date:  1987-08

2.  Left atrial extension of metastatic lung tumor via pulmonary vein: report on the first case of Ewing sarcoma.

Authors:  Yohei Funakoshi; Toru Mukohara; Tomoko Kataoka; Hideo Tomioka; Naoko Chayahara; Yutaka Fujiwara; Naomi Kiyota; Tomonori Shirasaka; Takanori Oka; Kenji Okada; Yutaka Okita; Shigeo Hara; Tomoo Itoh; Soichi Fumita; Kazuhiko Nakagawa; Hironobu Minami
Journal:  Rare Tumors       Date:  2010-09-30

Review 3.  Imaging procedures in the detection of cardiac tumors, with emphasis on echocardiography: a review.

Authors:  H G Bogren; A N DeMaria; D T Mason
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

4.  Right atrial tumor embolism from thoracic chondrosarcoma: A case report.

Authors:  Liyuan Lv; Xueqian Wang; Ying Zhang
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.